• Citer

Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials

par Caparica Bitton, Rafael ;Bruzzone, Marco;Poggio, Francesca;Ceppi, Marcello;de Azambuja, Evandro ;Lambertini, Matteo
Référence Breast cancer research and treatment, 174, 1, page (27-37)
Publication Publié, 2019-02

Article révisé par les pairs

• Détails
• Contenu

Titre:	Anthracycline and taxane-based chemotherapy versus docetaxel and cyclophosphamide in the adjuvant treatment of HER2-negative breast cancer patients: a systematic review and meta-analysis of randomized controlled trials
Auteur:	Caparica Bitton, Rafael; Bruzzone, Marco; Poggio, Francesca; Ceppi, Marcello; de Azambuja, Evandro; Lambertini, Matteo
Informations sur la publication:	Breast cancer research and treatment, 174, 1, page (27-37)
Statut de publication:	Publié, 2019-02
Sujet CREF:	Cancérologie
Mots-clés:	Adjuvant chemotherapy
	Anthracyclines
	Breast cancer
	Taxanes
Note générale:	SCOPUS: re.j
	DecretOANoAutActif
Langue:	Anglais
Identificateurs:	urn:issn:0167-6806
	info:doi/10.1007/s10549-018-5055-9
	info:scp/85056808804
	info:pmid/30465156